SITE DIRECTED MODIFICATION OF FVIII

PROBLEM TO BE SOLVED: To provide a biocompatible polymer-conjugated functional FVIII polypeptide having improved pharmacokinetic characteristics and therapeutic characteristics.SOLUTION: An isolated polypeptide conjugate having factor VIII procoagulant activity comprises a functional factor VIII pol...

Full description

Saved in:
Bibliographic Details
Main Authors STRAUSS JONATHAN S, TJANDRA HENDRI, BARNETT THOMAS, CHEN JIANMIN, MEI BAISONG, WANG DEQIAN, MURPHY JOHN E, PAN CLARK Q, TANG LIANG
Format Patent
LanguageEnglish
Japanese
Published 08.06.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide a biocompatible polymer-conjugated functional FVIII polypeptide having improved pharmacokinetic characteristics and therapeutic characteristics.SOLUTION: An isolated polypeptide conjugate having factor VIII procoagulant activity comprises a functional factor VIII polypeptide having heavy and light chains. The functional factor VIII polypeptide is covalently bound to one or more biocompatible polymers only in the heavy chain.SELECTED DRAWING: None 【課題】向上した薬物動態学的特性及び治療的特性を有する生物適合性ポリマー−複合機能性FVIIIポリペプチドを提供する。【解決手段】因子VIIIプロコアグラント活性を有する単離されたポリペプチド複合体であって、重鎖および軽鎖を有する機能性因子VIIIポリペプチドを含んでなり、該機能性因子VIIIポリペプチドが重鎖のみにおいて1個もしくはそれ以上の生物適合性ポリマーに共有結合している、上記単離されたポリペプチド複合体。【選択図】なし
Bibliography:Application Number: JP20160234756